Advertisement
Screener

TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Federal Income Tax Expense (Benefit), Continuing Operations

2.0 / 5 stars · 23/57 Roast Me

TEVA PHARMACEUTICAL INDUSTRIES LIMITED Federal Income Tax Expense (Benefit), Continuing Operations

TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) reported Federal Income Tax Expense (Benefit), Continuing Operations of $206.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.

Financial Statements › Expense Statement › Income Tax

us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-02-03

  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED federal income tax expense (benefit), continuing operations for fiscal 2025 was $206.00M, a 71.43% decline from fiscal 2024.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED federal income tax expense (benefit), continuing operations for fiscal 2024 was $721.00M.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED federal income tax expense (benefit), continuing operations for fiscal 2023 was -$402.00M, a 1318.18% decline from fiscal 2022.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED federal income tax expense (benefit), continuing operations for fiscal 2022 was $33.00M, a 73.39% decline from fiscal 2021.
Period endFederal Income Tax Expense (Benefit), Continuing Operations 12 month
2025-12-31$206.00M
10-K · filed 2026-02-03
2024-12-31$721.00M
10-K · filed 2026-02-03
2023-12-31-$402.00M
10-K · filed 2026-02-03
2022-12-31$33.00M
10-K · filed 2025-02-05
2021-12-31$124.00M
10-K · filed 2024-02-12
2020-12-31$60.00M
10-K · filed 2023-02-10
2019-12-31$107.00M
10-K · filed 2022-02-09
2018-12-31$131.00M
10-K · filed 2021-02-10
2017-12-31$96.00M
10-K · filed 2020-02-21
2016-12-31$209.00M
10-K · filed 2019-02-19
2015-12-31$149.00M
10-K · filed 2018-02-12
2014-12-31$147.00M
20-F · filed 2017-02-15
2013-12-31$197.00M
20-F · filed 2016-02-11
2012-12-31$5.00M
20-F · filed 2015-02-09
2011-12-31$71.00M
20-F · filed 2014-02-10
2010-12-31$139.00M
20-F · filed 2013-02-12
2009-12-31$48.00M
20-F · filed 2012-02-17
2008-12-31$145.00M
20-F · filed 2011-02-15